학술논문
Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02
Document Type
Article
Author
Source
In: Neuro-Oncology Advances . (Neuro-Oncology Advances, 1 January 2020, 2(1))
Subject
Language
English
ISSN
26322498